S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Laser breakthrough could send stock soaring 2,467% (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Laser breakthrough could send stock soaring 2,467% (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Laser breakthrough could send stock soaring 2,467% (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Laser breakthrough could send stock soaring 2,467% (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Laser breakthrough could send stock soaring 2,467% (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Laser breakthrough could send stock soaring 2,467% (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Laser breakthrough could send stock soaring 2,467% (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
Laser breakthrough could send stock soaring 2,467% (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
NASDAQ:CASI

CASI Pharmaceuticals (CASI) Stock Forecast, Price & News

$2.42
-0.15 (-5.84%)
(As of 06/9/2023 ET)
Compare
Today's Range
$2.40
$2.57
50-Day Range
$2.05
$3.70
52-Week Range
$1.45
$4.86
Volume
27,555 shs
Average Volume
32,280 shs
Market Capitalization
$32.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

CASI Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
313.2% Upside
$10.00 Price Target
Short Interest
Healthy
3.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
0.00mentions of CASI Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.88) to ($0.45) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.25 out of 5 stars

Medical Sector

280th out of 987 stocks

Biological Products, Except Diagnostic Industry

40th out of 156 stocks


CASI stock logo

About CASI Pharmaceuticals (NASDAQ:CASI) Stock

CASI Pharmaceuticals, Inc. engages in developing and commercializing therapeutics and pharmaceutical products. The company was founded in 1991 and is headquartered in Beijing, China.

Receive CASI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CASI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CASI Stock News Headlines

Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
BTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP)
See More Headlines

CASI Price History

CASI Company Calendar

Last Earnings
11/12/2021
Today
6/10/2023
Next Earnings (Estimated)
8/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CASI
Employees
176
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+313.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-41,010,000.00
Pretax Margin
-82.20%

Debt

Sales & Book Value

Annual Sales
$43.11 million
Book Value
$3.28 per share

Miscellaneous

Free Float
10,492,000
Market Cap
$32.23 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Wei-Wu HeWei-Wu He
    Chairman & Chief Executive Officer
  • Wei Zhang
    President & Chief Financial Officer
  • Chun Hua Wang
    Chief Operation Officer
  • Alexander A. Zukiwski
    Chief Medical Officer & Executive Vice President
  • Fu Qiang Zhang
    Chief Commercial Officer













CASI Stock - Frequently Asked Questions

Should I buy or sell CASI Pharmaceuticals stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CASI Pharmaceuticals in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CASI shares.
View CASI analyst ratings
or view top-rated stocks.

What is CASI Pharmaceuticals' stock price forecast for 2023?

2 brokers have issued 12 month price targets for CASI Pharmaceuticals' shares. Their CASI share price forecasts range from $10.00 to $10.00. On average, they predict the company's stock price to reach $10.00 in the next year. This suggests a possible upside of 313.2% from the stock's current price.
View analysts price targets for CASI
or view top-rated stocks among Wall Street analysts.

How have CASI shares performed in 2023?

CASI Pharmaceuticals' stock was trading at $1.79 on January 1st, 2023. Since then, CASI shares have increased by 35.2% and is now trading at $2.42.
View the best growth stocks for 2023 here
.

When is CASI Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 11th 2023.
View our CASI earnings forecast
.

How were CASI Pharmaceuticals' earnings last quarter?

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) announced its quarterly earnings data on Friday, November, 12th. The biotechnology company reported ($0.70) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.10. The biotechnology company earned $8.11 million during the quarter, compared to analyst estimates of $7.77 million. CASI Pharmaceuticals had a negative trailing twelve-month return on equity of 72.23% and a negative net margin of 90.65%. During the same quarter in the previous year, the business earned ($1.40) EPS.

When did CASI Pharmaceuticals' stock split?

CASI Pharmaceuticals's stock reverse split on Wednesday, June 1st 2022. The 1-10 reverse split was announced on Wednesday, June 1st 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 1st 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of CASI Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CASI Pharmaceuticals investors own include NVIDIA (NVDA), OPKO Health (OPK), Caladrius Biosciences (CLBS), Overstock.com (OSTK), Riot Platforms (RIOT), Boeing (BA), Enphase Energy (ENPH), Catalyst Pharmaceuticals (CPRX), Pure Storage (PSTG) and QUALCOMM (QCOM).

What is CASI Pharmaceuticals' stock symbol?

CASI Pharmaceuticals trades on the NASDAQ under the ticker symbol "CASI."

Who are CASI Pharmaceuticals' major shareholders?

CASI Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Shields Capital Management LLC (1.35%), Wellington Shields & Co. LLC (1.05%) and Susquehanna International Group LLP (0.29%). Insiders that own company stock include James Huang, Larry Zhang, Weihao Xu and Wei-Wu He.
View institutional ownership trends
.

How do I buy shares of CASI Pharmaceuticals?

Shares of CASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CASI Pharmaceuticals' stock price today?

One share of CASI stock can currently be purchased for approximately $2.42.

How much money does CASI Pharmaceuticals make?

CASI Pharmaceuticals (NASDAQ:CASI) has a market capitalization of $32.23 million and generates $43.11 million in revenue each year. The biotechnology company earns $-41,010,000.00 in net income (profit) each year or ($2.83) on an earnings per share basis.

How many employees does CASI Pharmaceuticals have?

The company employs 176 workers across the globe.

How can I contact CASI Pharmaceuticals?

CASI Pharmaceuticals' mailing address is 9620 MEDICAL CENTER DR STE 300, ROCKVILLE MD, 20850. The official website for the company is www.casipharmaceuticals.com. The biotechnology company can be reached via phone at 861065086063, via email at ir@casipharmaceuticals.com, or via fax at 301-315-2437.

This page (NASDAQ:CASI) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -